Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by flice inhibitor protein and bcl-2

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4864-4872

  Poulaki, Vassiliki ^a   Mitsiades, Nicholas ^a   Romero, Maria E ^a   Tsokos, Maria ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CASPASE 8; CYTOCHROME C; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; GENE PRODUCT; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN BINDING; SENSITIZATION; SIGNAL TRANSDUCTION; TUMOR CELL;

ADOLESCENT; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CHILD; CHILD, PRESCHOOL; CYTOCHROME C GROUP; ENZYME ACTIVATION; HUMANS; INFANT; INFANT, NEWBORN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; NEUROBLASTOMA; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0035874993     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Current aspects of biology, risk assessment, and treatment of neuroblastoma
2. Activation of programmed cell death by anticancer agents: Cisplatin as a model system
3. Induction of apoptosis by cancer chemotherapy
4. Cytotoxic drugs and the CD95 pathway
5. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
6. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
7. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
8. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells
9. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
10. Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma
11. CD95/Fas/Apo-1 mediated signal transduction
12. Two CD95 (APO-1/Fas) signaling pathways
13. Bid, a bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
14. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
15. An APAF-1. Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
16. Differential modulation of apoptosis sensitivity in CD95 type 1 and type II cells
17. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
18. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins
19. Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene
20. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture
21. Cytogenetic characterization of selected small round cell tumors of childhood
22. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
23. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
24. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis
25. Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex
26. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal
27. The statistics of synergism
28. Differential expression of bcl2 proto-oncogene in neuroblastoma and other human tumor cell lines of neural origin
29. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
30. The Fas antibody down-regulates the bcl-2 protein but does not induce apoptosis in neuroblastoma
31. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/α and caspase-8/β
32. The role of c-FLIP in modulation of CD95-induced apoptosis
33. The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis
34. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked
35. Bcl-2 family proteins and mitochondria
36. Cif (Cytochrome c efflux-inducing factor) activity is regulated by bcl- 2 and caspases and correlates with the activation of Bid
37. Molecular characterization of mitochondrial apoptosis-inducing factor
38. Cellular death in neuroblastoma: In situ correlation of apoptosis and bcl-2 expression
39. Relationship between bcl-2 and myc gene expression in human neuroblastoma
40. Expression of bcl-2 gene product in neuroblastoma
41. An immunohistochemical analysis of mdr-1 and bcl-2 expressions in neuroblastoma
42. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma
43. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression
44. Caspase 8 protein expression in tumor specimens from 71 neuroblastoma patients
45. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells
46. MycN sensitizes neuroblastoma cells for drug-induced apoptosis
47. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
48. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
49. Inhibition of death receptor signals by cellular FLIP
50. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
51. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
52. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
53. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells
54. The inhibitor of death receptor signaling. FLICE-inhibitory protein defines a new class of tumor progression factors
55. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
56. Inhibition of Fas-induced apoptosis by bcl-2
57. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma
58. Interaction and regulation of subcellular localization of CED-4 by CED-9
59. Boo, a novel negative regulator of cell death, interacts with Apaf-1
60. Diva, a bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death
61. Bcl-2 targets the protein kinase Raf-1 to mitochondria
62. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and bcl-2
63. BAR. An apoptosis regulator at the intersection of caspases and bcl-2 family proteins
64. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression
65. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
66. Differentiation of neuroblastoma enhances bcl-2 expression and induces alterations of apoptosis and drug resistance
67. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice
68. Eradication of human non-Hodgkin's lymphoma in SCID mice by bcl-2 antisense oligonucleotides combined with low-dose cyclophosphamide
69. Phase 1 clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma
70. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector
71. Structure-based discovery of an organic compound that binds bcl-2 protein and induces apoptosis of tumor cells